Protection of BALB/c mice from respiratory syncytial virus infection by immunization with a synthetic peptide derived from the G glycoprotein.
about
Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice.A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5).Conserved cysteine residues within the attachment G glycoprotein of respiratory syncytial virus play a critical role in the enhancement of cytotoxic T-lymphocyte responsesActive and passive immunisation against respiratory syncytial virus.CD4(+) T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment.Respiratory syncytial virus genetic and antigenic diversity.Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein.Respiratory syncytial virus vaccinesCarrier properties of a protein derived from outer membrane protein A of Klebsiella pneumoniae.The respiratory syncytial virus G protein conserved domain induces a persistent and protective antibody response in rodentsGamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial virus G protein fragmentRecombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease.Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus.Determination of the disulfide bond arrangement of human respiratory syncytial virus attachment (G) protein by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.Universal vaccine against respiratory syncytial virus A and B subtypes.Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus.Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infectionFirst peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs.Bovine respiratory syncytial virus protects cotton rats against human respiratory syncytial virus infection.Surface display on staphylococci: a comparative study.The host response and molecular pathogenesis associated with respiratory syncytial virus infection.Targeting RSV with vaccines and small molecule drugs.Antigenic structure of the central conserved region of protein G of bovine respiratory syncytial virus.Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton ratsGeneration and epitope mapping of a sub-group cross-reactive anti-respiratory syncytial virus G glycoprotein monoclonal antibody which is protective in vivo.Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.Synthesis and characterization of Respiratory Syncytial Virus protein G related peptides containing two disulfide bridges.RSV replication is promoted by autophagy-mediated inhibition of apoptosis.
P2860
Q33558356-3953C371-2256-42C7-A257-88D98AAB26FAQ33690612-64A6EFCE-F12D-4B2F-A83F-21568E88B334Q33754172-8985287E-15F5-4924-AEFA-0FF782BBEA04Q33782438-931468C6-DB72-4DD5-A065-3B8F3E4BFE18Q33801890-4DE045CB-E4E8-48B7-90F2-89207EA819FAQ33812405-9160DD2F-310B-44A5-B9C0-F1C0BC8E0B40Q33815412-4883186B-4CA2-417B-95EE-63C70F6B88DAQ33975330-CA368A80-343B-447D-BA63-79B305D7F771Q34002277-FA036D50-DE7B-4F98-BF0B-1FD5B3170F07Q34222406-8F84A1F0-4EAB-433A-BB45-076635F38EBFQ34347904-82260598-0AC7-4321-963D-13048C1457F6Q35070505-C44795E1-E11E-4402-B21C-9BEDAD9D48C1Q35872191-A873F3FE-8E1D-43C0-82B8-7772F09D2E3DQ36280388-0CC46B3F-10B4-4E7C-9B09-C30925F7998BQ36338294-61D01C99-D5E1-4FB7-95DC-289AF097C13CQ36401291-409074E1-32C7-4637-8272-D597190E0DA5Q36483809-A223CC23-C991-4611-8DB4-2CEECE84FBCCQ36622661-76985421-CC5C-4BED-A0A2-9691E63F839FQ36643763-66DB43DD-709F-41D6-8DAF-83585250FAC9Q36807872-C14032F5-9970-4D61-A74D-ECC5BBDD282CQ37263779-DE182694-283C-45CC-95DA-CD09250FF592Q37328584-FED1EA15-62DD-4020-B422-7B5BDF69650BQ39879510-1C691835-ED80-4E1E-8EF1-D51AD7CBCFBBQ40402380-A51E1963-3017-4D3D-AE53-C1F7C668CAFAQ42243843-1003CADD-C96B-4C09-B193-01DF58BCEAFFQ43697170-1F1F9BC9-84B9-4EE1-8B44-C9DBDB645071Q44312459-41D81E34-A334-4213-8035-9150D3BF5390Q47547486-D7A41CD2-835B-4DE8-BF74-684B9ABB5516
P2860
Protection of BALB/c mice from respiratory syncytial virus infection by immunization with a synthetic peptide derived from the G glycoprotein.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Protection of BALB/c mice from ...... rived from the G glycoprotein.
@en
Protection of BALB/c mice from ...... rived from the G glycoprotein.
@nl
type
label
Protection of BALB/c mice from ...... rived from the G glycoprotein.
@en
Protection of BALB/c mice from ...... rived from the G glycoprotein.
@nl
prefLabel
Protection of BALB/c mice from ...... rived from the G glycoprotein.
@en
Protection of BALB/c mice from ...... rived from the G glycoprotein.
@nl
P2093
P1433
P1476
Protection of BALB/c mice from ...... rived from the G glycoprotein.
@en
P2093
P304
P356
10.1016/0042-6822(91)90546-N
P407
P577
1991-12-01T00:00:00Z